Literature DB >> 27976803

CD31+ Cells From Peripheral Blood Facilitate Bone Regeneration in Biologically Impaired Conditions Through Combined Effects on Immunomodulation and Angiogenesis.

F Andrea Sass1,2, Katharina Schmidt-Bleek1,2, Agnes Ellinghaus1, Sebastian Filter1, Alexander Rose1, Bernd Preininger3, Simon Reinke1,2, Sven Geissler1,2, Hans-Dieter Volk2,4, Georg N Duda1,2, Anke Dienelt1,2.   

Abstract

Controlled revascularization and inflammation are key elements regulating endogenous regeneration after (bone) tissue trauma. Peripheral blood-derived cell subsets, such as regulatory T-helper cells and circulating (endothelial) progenitor cells, respectively, can support endogenous tissue healing, whereas effector T cells that are associated with an aged immune system can hinder bone regeneration. CD31 is expressed by diverse leukocytes and is well recognized as a marker of circulating endothelial (precursor) cells; however, CD31 is absent from the surface of differentiated effector T cells. Thus, we hypothesized that by separating the inhibitory fractions from the supportive fractions of circulating cells within the peripheral blood (PB) using the CD31 marker, bone regeneration in biologically compromised conditions, such as those observed in aged patients, could be improved. In support of our hypothesis, we detected an inverse correlation between CD31+ cells and effector T cells in the hematomas of human fracture patients, dependent on the age of the patient. Furthermore, we demonstrated the regenerative capacity of human PB-CD31+ cells in vitro. These findings were translated to a clinically relevant rat model of impaired bone healing. The transplantation of rat PB-CD31+ cells advanced bone tissue restoration in vivo and was associated with an early anti-inflammatory response, the stimulation of (re)vascularization, and reduced fibrosis. Interestingly, the depletion or enrichment of the highly abundant CD31+/14+ monocytes from the mixed CD31+ cell population diminished tissue regeneration at different levels, suggesting combined effects within the PB-CD31+ subsets. In summary, an intraoperative enrichment of PB-CD31+ cells might be a novel option to facilitate endogenous regeneration under biologically impaired situations by supporting immunomodulation and vascularization.
© 2016 American Society for Bone and Mineral Research. © 2016 American Society for Bone and Mineral Research.

Entities:  

Keywords:  INJURY/FRACTURE HEALING; OSTEOIMMUNOLOGY; PRECLINICAL STUDIES

Mesh:

Substances:

Year:  2017        PMID: 27976803     DOI: 10.1002/jbmr.3062

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  9 in total

Review 1.  Current and future uses of skeletal stem cells for bone regeneration.

Authors:  Guo-Ping Xu; Xiang-Feng Zhang; Lu Sun; Er-Man Chen
Journal:  World J Stem Cells       Date:  2020-05-26       Impact factor: 5.326

2.  Biophysical induction of cell release for minimally manipulative cell enrichment strategies.

Authors:  Pascal Joly; Thomas Schaus; Andrea Sass; Anke Dienelt; Alexander S Cheung; Georg N Duda; David J Mooney
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

3.  A review of biomaterials in bone defect healing, remaining shortcomings and future opportunities for bone tissue engineering: The unsolved challenge.

Authors:  T Winkler; F A Sass; G N Duda; K Schmidt-Bleek
Journal:  Bone Joint Res       Date:  2018-05-05       Impact factor: 5.853

Review 4.  Immunology Guides Skeletal Muscle Regeneration.

Authors:  F Andrea Sass; Michael Fuchs; Matthias Pumberger; Sven Geissler; Georg N Duda; Carsten Perka; Katharina Schmidt-Bleek
Journal:  Int J Mol Sci       Date:  2018-03-13       Impact factor: 5.923

5.  Retrospective Analysis of the Clinical Outcome in a Matched Case-Control Cohort of Polytrauma Patients Following an Osteosynthetic Flail Chest Stabilization.

Authors:  Marcel Niemann; Frank Graef; Serafeim Tsitsilonis; Ulrich Stöckle; Sven Märdian
Journal:  J Clin Med       Date:  2020-07-26       Impact factor: 4.241

6.  Compromised Bone Healing in Aged Rats Is Associated With Impaired M2 Macrophage Function.

Authors:  Julia Löffler; F Andrea Sass; Sebastian Filter; Alexander Rose; Agnes Ellinghaus; Georg N Duda; Anke Dienelt
Journal:  Front Immunol       Date:  2019-10-18       Impact factor: 7.561

7.  Identification of circulating CD31+CD45+ cell populations with the potential to differentiate into erythroid cells.

Authors:  Maria Chiara G Monaco; Dragan Maric; Ombretta Salvucci; Cristina Antonetti Lamorgese Passeri; Patrizia Accorsi; Eugene O Major; Anna Concetta Berardi
Journal:  Stem Cell Res Ther       Date:  2021-04-13       Impact factor: 6.832

8.  Keratin 17 upregulation promotes cell metastasis and angiogenesis in colon adenocarcinoma.

Authors:  Ran Ji; Yifei Ji; Lin Ma; Sijia Ge; Jing Chen; Shuzhen Wu; Tianxin Huang; Yu Sheng; Liyang Wang; Nan Yi; Zhaoxiu Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

9.  Irisin promotes fracture healing by improving osteogenesis and angiogenesis.

Authors:  Tianyou Kan; Zihao He; Jingke Du; Mingming Xu; Junqi Cui; Xuequan Han; Dake Tong; Hanjun Li; Mengning Yan; Zhifeng Yu
Journal:  J Orthop Translat       Date:  2022-09-24       Impact factor: 4.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.